FY ended March 2018

• Japan: Sales increased 2.7%, as the Company concentrated on enhancing sales activities which match each market; the acute care hospital market, the small and mid-sized hospital market, and the clinic market. Consumables and services also contributed to sales increase. Sales in the university hospital market increased favorably as the Company received orders related to replacement of diagnostic information systems and clinical information systems. Sales of AEDs increased favorably in the PAD market and sales in the private hospital market showed stable growth. Sales in the public hospital market remained flat, while sales in the clinic market decreased. 
• International: Sales increased 11.0%. Sales in the Americas, Europe and Asia increased favorably, supported by strong sales of Patient Monitors, defibrillators and AEDs. 

• Americas: Sales increased 16.1%. Sales showed strong growth both in the U.S. and Latin America. 
• Europe: Sales increased 21.1% supported by strong sales in Russia and sales recovery in Germany and Turkey. 
• Asia: Sales increased 7.9%. Sales in China increased favorably. Sales in the Middle East recovered as a result of developing distribution channels.
• Other： Sales decreased 31.6% compared with the previous fiscal year when a large order in Egypt was recorded.